Corbus Pharmaceuticals Holdings, INC
pharmaceutical company developing therpeutics to treat inflammatory and fibrotic diseases.
Based in MA
🤖
AI Overview
With $386K in lobbying spend across 11 quarterly filings, Corbus Pharmaceuticals Holdings, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2020.
$386K
Total Spend
3
Years Active
1
Firms Hired
4
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $60K |
| 2019 | $180K |
| 2020 | $146K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •Issues related to drug scheduling regulations at the Drug Enforcement Administration and Food Drug Administration.
- •Drug Enforcement Agency scheduling of Cannabinoids. Registration of clinical trial sites.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.